Director Mikael Dolsten filed a statement of changes in beneficial ownership with the SEC on September 9, 2026, disclosing a sale of Agilent Technologies, Inc. common stock on September 4, 2026.
Key Highlights
- Reporting Person: Mikael Dolsten, listed as a Director of Agilent Technologies, Inc. (NYSE:A)
- Shares Sold: 634 shares of common stock disposed of (transaction code S) on September 4, 2026, at a price of $151.375 per share
- Post-Transaction Holdings: Dolsten held 4,923.68 shares beneficially owned following the reported transaction, held directly
- Dividend Reinvestment: The post-transaction total includes 9.295 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan, in transactions exempt under Rule 16a-11, with those shares deferred by the reporting person
- Filing Date: The statement was filed on September 9, 2026, and signed by Shirley Qin as attorney-in-fact for Mr. Dolsten
Dolsten's Share Disposal and Ownership Position at Agilent Technologies
According to the filing, Mikael Dolsten, serving as a Director of Agilent Technologies, Inc., disposed of 634 shares of the company's common stock on September 4, 2026. The transaction was recorded under transaction code S, indicating an open-market sale, at a price of $151.375 per share. Agilent Technologies is a life sciences and diagnostics instrumentation company traded on the New York Stock Exchange under the ticker symbol A.
Following the reported sale, the filing discloses that Dolsten held a total of 4,923.68 shares of Agilent common stock directly. The filing notes that this figure includes 9.295 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan, in transactions the filing describes as exempt under Rule 16a-11. According to the filing, the reporting person has elected to defer these dividend reinvestment plan shares. No derivative securities transactions were reported in Table II of the filing.
What Was Disclosed
The filing disclosed a September 4, 2026, sale of 634 shares of Agilent Technologies common stock by Director Mikael Dolsten at $151.375 per share, leaving him with directly held beneficial ownership of 4,923.68 shares, including deferred dividend reinvestment plan shares.






Please wait processing your request...